Sreetama Dutt

Sreetama Dutt

B.Tech. Biotechnology Engineering, M.Sc. Medical Microbiology

Sreetama Dutt has completed her B.Tech. in Biotechnology from SRM University in Chennai, India and holds an M.Sc. in Medical Microbiology from the University of Manchester, UK. Initially decided upon building her career in laboratory-based research, medical writing and communications happened to catch her when she least expected it. Of course, nothing is a coincidence.

See more

Sreetama has always been passionate about writing. As a child she would always scribble in any random piece of paper she got, be it scrap paper, a notebook, or her grandfather’s brand new organizer, all she ever needed was a pen. And this somehow stayed with her for as long as she can remember.

Sreetama started freelancing right after completing her master’s degree. Mingling her passion for writing and her core subject matters seemed to be the best career path for her. As a part of her first assignment, she authored and co-authored multiple articles, news reports, press releases, and blogs for online news channels. The thought of connecting with people through her work and spreading the word on the latest in healthcare, pharmaceuticals and technology gave her immense joy.

For the past 7 years, there has been no looking back for Sreetama. From being employed in various start-ups, working on niche areas like ophthalmology and oncology, to working with entrepreneurs and innovators, independently, Sreetama has found herself authoring every form of document – be it abstracts, white papers, website content, articles, newsletters, and peer-reviewed publications. Sreetama has 5 peer-reviewed publications so far, in reputed journals, with more to come.

In her free time, Sreetama enjoys dancing, music, and reading. She loves to explore new places and meet new people. On a day off, you will find her exploring new cafés in the city, looking up the latest in fashion, or snuggling in a blanket with a book in hand.

See less

Articles from Sreetama

Deficient spike-specific T cell responses and inability to neutralize SARS-CoV-2 variants 12 month post-infection

Deficient spike-specific T cell responses and inability to neutralize SARS-CoV-2 variants 12 month post-infection

A study of livestock exposure to the SARS-CoV-2 virus

A study of livestock exposure to the SARS-CoV-2 virus

Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

Development of SARS-CoV-2 detection platform using surface-enhanced Raman spectroscopy

Development of SARS-CoV-2 detection platform using surface-enhanced Raman spectroscopy

Pre-clinical follow-up study boosting with original formulation and next generation INO-4802 SARS-CoV-2 vaccine candidate

Pre-clinical follow-up study boosting with original formulation and next generation INO-4802 SARS-CoV-2 vaccine candidate

Dutch study compares mRNA vaccines to vector-based vaccines for COVID-19

Dutch study compares mRNA vaccines to vector-based vaccines for COVID-19

Curious case of SARS-CoV-2 Delta variant in a dog

Curious case of SARS-CoV-2 Delta variant in a dog

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Taking lessons in molecular therapeutics from earthworms to combat COVID

Taking lessons in molecular therapeutics from earthworms to combat COVID

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19

Study shows efficacy of a heterologous vaccine regimen to induce mucosal protection against COVID-19